Echo-doppler velocimetric indices are widely used for diagnosing renal artery stenosis (RAS) but it is unclear to what extent they reflect the renal hemodynamics in stenotic and non stenotic kidneys(SK and NSK). We measured pulsality and resistive indices (PI and RI), acceleration (A) and acceleration time (AT) as well as effective plasma flow (ERPF, ml/min), glomerular filtration rate (GFR, ml/min),renal vascular resistance(RVR) and filtration fraction (FF) estimated by single kidney scintigraphy in 24 SK with 70-95% RAS (17 atherosclerotic and 7 fibromuscular) and in 27 NSK (11 controlateral to RAS and 16 of patients with essential hypertension). In SK these studies were repeated after a technically succesfull percutaneous transluminal angioplasty (PTRA in 11 cases combined with stent implantation). Before PTRA SK had lower values of ERPF and GFR and higher RVR than NSK (respectively 132ϩ/-10 vs 187ϩ/-10,35,8ϩ/-3.7vs 50.2ϩ/-3.4 and 1.02ϩ/-0.1 vs 0.65ϩ/-0.1 pϽ 0.05 or more) whereas FF was similar (0.27ϩ/-0.01 vs 0.26ϩ/-0.01);also PI,RI,A and AT were significantly different in SK and NSK (respectively 0.82ϩ/-0.04vs 1.15ϩ/-0.07,0.52ϩ/-0.02 vs 0.64 ϩ/-0.02,5.6ϩ/-0.9vs 18.6ϩ/-1.9 and 106ϩ/-8 vs 36ϩ/-2,p Ͻ 0.05 or more).In NSK we found significant relationships between PI and ERPF and RVR (rϭ-0.68 and 0.81,pϽ 0;01); also RI was correlated with ERPF and RVR (rϭ-0.67 and 0.78,pϽ 0.01) whereas no correlations were found with GFR and FF. Similarly there were no correlations between A and AT and ERPF, GFR,RVR and FF. In SK none of the four velocimetric indices was correlated with renal parameters. After PTRA, ERPF and GFR rose respectively to 162ϩ/-11 and 41.1ϩ/-3.8 whereas RVR fell to 0.75 ϩ/-0.06(pϽ 0.05 at least),FF was unchanged (0.26ϩ/-0.01) and PI,RI,A and AT became similar to NSK (1.5ϩ/-0.1, 0.69ϩ/-0.02,18.4ϩ/-1.0 and 35ϩ/-2). Moreover in poststenotic kidney (PSK) the relationships between PI,RI and ERPF and RVR were restored as in NSK(respectively rϭ-0.68 and -0.69, 0.8 and 0.72 pϽ 0.01 or more). Thus only PI and RI are valid indicators of ERPF and RVR in NSK and PSK while none of these velocimetrics indices reflect the renal hemodynamics in SK. A number of observations prompted us to explore the PTHrP system in renal vessels of SHR. First, the kidney is acknowledged as a major target of the dilatory effect of PTHrP in human and animal studies. Second, genetically determined renal mechanisms, including high renal vascular resistance (RVR), play a major role in the development of primary hypertension. Third, PTHrP mRNA has been shown to be upregulated in the aorta in genetic, as well as experimental hypertension. Finally, we reported earlier that the vasodilatory effect of PTHrP was reduced in SHR isolated perfused kidney (IPK), as compared to normotensive animals.
We now report that in small arteries isolated from kidney of 12-weekold SHR, immunoreactive PTHrP expression was increased by~40 %, while both PTH1 receptor (PTH1R) mRNA (RT-PCR) and protein (Western blot) were decreased by~60-80 %, as compared to age-matched WKY rats (pϽ0.05). These observations suggested potential beneficial effects of somatic human (h)PTH1R gene delivery to decrease RVR in SHR. To test this possibility, the hPTH1R DNA (1.9 kb), under the control of the cytomegalovirus promoter in the pcDNA1.1 vector was generated. The naked DNA construct (0.5mg) was delivered into SHR via a single intravenous injection. Control-treated SHR received 0.5mg empty vector. Three weeks after plasmid delivery, the expression of hPTH1R mRNA was identified by RT-PCR analysis in all main organs, including hearth, brain, aorta, liver and lungs. In kidney, hPTH1R transcipt was preferentially expressed in isolated intrarenal arteries as compared to total kidney. In IPKs, a submaximal concentration of PTHrP(1-36) (10 nM) decreased the preconstrictiopn induced by 10 M phenylephrine, by 19Ϯ11 % in control-treated SHR (nϭ5, pϾ0.05) This vasodilatory effect was increased to 54Ϯ8 % (nϭ5, pϽ0.05) in PTH1Rtransfected SHR. PTH1R gene delivery, also decreased basal RVR of the IPK from 7.2Ϯ0.2 (nϭ9) in control-treated to 5.2Ϯ0.3 mmHg min g ml -1 (nϭ13) in hPTH1R-transfected (pϽ0.05). Finally, infusion of 40nM PTHrP(3-36), an antagonist of PTH1R, had no effect in control-treated SHR, but displayed vasoconstrictory effect, increasing basal RVR in IPK by~13 % (nϭ4, pϽ0.05) in PTH1R-transfected SHR.
Collectively, these results strongly suggest that downregulation of PTH1R contributes to high RVR in SHR, despite the upregulation of its endogenous ligand. Replenishment of renal vascular pool of PTH1R by somatic gene delivery decreased RVR, owing to endogenous vasodilatory PTHrP. Thus, in SHR, endogenous PTHrP system modulates renal tonus, at least in vitro.
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